Inventaire - vos ami⋅e⋅s et communautés sont votre meilleure bibliothèque

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.

auteur·ice

Francesca Ceccherini-Silberstein

Antonella d'Arminio Monforte

Andrea Gori

Andrea Costantini

Massimo Puoti

Antonella Cingolani

Milensu Shanyinde

Alessandro Cozzi-Lepri

Andrea Giacometti

Fiona C Lampe

publié dans: European Journal of Clinical Microbiology & Infectious Diseases

date de publication: 2018-01-09

Articles cités 20

Date

Titre

Auteur·ices

2016-03-01

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy

Alessandro Cozzi-Lepri, Icona Foundation Study Group, Andrea Costantini, Antonio Di Biagio, Antonella Castagna, Andrea De Luca, Andrea Antinori, Andrea Gori, Laura Monno, Camilla Tincati, Emanuele Nicastri, Roberta Prinapori, Tiziana Quirino, Cristina Mussini, Giuliano Rizzardini, Antonella d'Arminio Monforte
2015-02-26

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients

Simona Di Giambenedetto, Eugenia Quiros-Roldan, Andrea Gori, Alessia Zoncada
2014-06-05

HIV infection: epidemiology, pathogenesis, treatment, and prevention

Connie Celum, Gary Maartens, Sharon R. Lewin
2014-02-01

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

Amanda Mocroft, Daniel Grint, Jens Lundgren, Brygida Knysz, Stéphane De Wit, Ole Kirk, Juergen K Rockstroh, EuroSIDA in EuroCoord, Victor M Mitsura
2014-07-01

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort

Laura Ambra Nicolini, Alessandro Cozzi-Lepri, Antonella d'Arminio Monforte, Antonio Di Biagio, Massimo Andreoni, Andrea Antinori, Andrea Gori, Cristina Mussini, Patrizia Lorenzini, Massimo Puoti, Jacopo Vecchiet, Claudio Viscoli
2013-04-01

Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients

José Vicente Fernández-Montero, Vicente Soriano
2013-03-21

Hepatoxicity of new antiretrovirals: a systematic review
2012-11-12

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Simona Di Giambenedetto, Manuela Colafigli, Massimiliano Fabbiani, Roberto Cauda, Alessandro D'Avino, Annalisa Mondi, Mattia A Prosperi, Iuri Fanti, Zaccarelli Mauro
2012-10-16

Decreasing rate of multiple treatment modifications among individuals who initiated antiretroviral therapy in 1997-2009 in the Danish HIV Cohort Study

Marie Helleberg, Alex Lund Laursen
2012-04

Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

Karin Neukam, Hernando Knobel, Juan Macías, Juan A. Pineda, Bonaventura Clotet i Sala, Josep Mallolas, José A. Cartón, María J. Jiménez-Expósito
2011-01-19

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort
2011-09-07

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients

Karin Neukam, Juan Macías, Juan A. Pineda, Angela S Camacho, Almudena Torres-Cornejo, Josefa Ruiz-Morales, Ignacio de Los Santos-Gil, Mercedes González-Serrano
2009-09-01

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

Antonella d'Arminio Monforte
2008-01-01

Antiretroviral drugs and liver injury

Vicente Soriano
2006-08-01

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Caroline Sabin, Nina Friis-Møller, Antonella d'Arminio Monforte, Stéphane De Wit, François Dabis, Wafaa El-Sadr, Bruno Ledergerber, Andrew N Phillips, Jens Lundgren, Ole Kirk, Peter Reiss
2006-06-01

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Nathan Clumeck, Julio Montaner, Mark Sulkowski, David L Thomas
2005-01-21

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection
2000-12-01

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

Peter Reiss
2000-03-01

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

Giuseppe Ippolito, Patrizio Pezzotti, Giovanni Rezza, Antonella d'Arminio Monforte
1992-12-18

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Article - wd:Q50110013

Bienvenue sur Inventaire

la bibliothèque de vos ami⋅e⋅s et communautés